Providence Capital Advisors’s Encompass Health EHC Stock Holding History

Providence Capital Advisors’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-35	Closed	-$2K	–	333
2022 Q1	$2K	Buy	+35	New	+$1.83K	﹤0.01%	348

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Providence Capital Advisors's EHC Position: Q2 2022 in Review

Providence Capital Advisors sold out of Encompass Health (EHC) in Q2 2022, closing a stake of 35 shares — an estimated $2K sold.

Providence Capital Advisors first reported a position in EHC in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 394 funds tracked by Wall St. Rank hold EHC as of Q2 2022.

Providence Capital Advisors reported no remaining Encompass Health position as of Q2 2022 after selling out during the quarter.
Providence Capital Advisors sold 35 Encompass Health shares in Q2 2022, an estimated $2K.
Providence Capital Advisors first reported a position in Encompass Health in Q1 2022 and held it in 1 quarter.
Providence Capital Advisors's Encompass Health position peaked at $2K in Q1 2022.
394 funds tracked by Wall St. Rank held Encompass Health as of Q2 2022.

Based on Providence Capital Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.